JFL Life Sciences Ltd.

40.90 +0.55 ▲1.4%

23 April 2024, 03:59:57 PM
Volume: 10,000

Company Profile

Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.jfllifesciences.com
Market Cap 44.38 Cr.
Enterprise Value(EV) 49.88 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 2.55 Trailing Twelve Months Ending 2023-03
Price-Earning Ratio (PE) 15.79 Trailing Twelve Months Ending 2023-03
Industry PE 41.25 Trailing Twelve Months Ending 2023-03
Book Value / Share 29.34 Trailing Twelve Months Ending 2023-03
Price to Book Value 1.38 Calculated using Price: 40.35
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 1.10 Cr. 10,998,441 Shares
FaceValue 10
About JFL Life Sciences Ltd.
JFL Life Sciences manufactures a wide range of pharmaceutical formulations. The company’s major products types are Dry powder injections; Tablets & Capsules (B-Lactam) solid oral dosage form; Tablet and capsules (General); and Oral Rehydration Solutions (ORS).

JFL Life Sciences Ltd. Delivery

Delivered Qty
Traded Qty

JFL Life Sciences Ltd. Performance

1 Day
+1.36%
1 Week
+2.25%
1 Month
+2.25%
3 Month
-13.71%
6 Month
-15.58%
1 Year
-4.88%
2 Year
5 Year
10 Year

JFL Life Sciences Ltd. Fundamental Ratios

5 years 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 6.03 6.94 8.85 30.94 12.9
Return on Capital Employed (%) 8.71 11.8 10.32 23.14 15.44
Return on Assets (%) 1.87 1.78 2.03 7.27 5.77

JFL Life Sciences Ltd. Balance Sheet

Particulars 6 years 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 5 5 7 11 32 34
Non Curr. Liab. 3 1 8 9 2 1
Curr. Liab. 8 18 14 28 15 18
Minority Int.
Equity & Liab. 16 24 29 48 49 53
Non Curr. Assets 3 6 9 9 8 8
Curr. Assets 14 18 20 39 41 46
Misc. Exp. not W/O
Total Assets 16 24 29 48 49 53

JFL Life Sciences Ltd. Profit and Loss

Particulars 5 years 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Net Sales 32 30 33 34 43
Other Income 0 0 1 2
Total Income 32 30 33 34 44
Total Expenditure -30 -28 -31 -28 -39
PBIDT 1 2 2 6 6
Interest -1 -1 -1 -2 -1
Depreciation 0 0 0 0 0
Taxation 0 0 0 -1 -1
Exceptional Items
PAT 0 0 1 3 3
Adjusted EPS 1 1 1 4 3

JFL Life Sciences Ltd. Cash Flow

Particulars 5 years 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. -3 3 -6 2 -9
Cash Fr. Inv. -1 -3 -2 -1 1
Cash Fr. Finan. 4 0 7 -1 8
Net Change 0 0 0 0
Cash & Cash Eqvt 0 0 0 0 0

JFL Life Sciences Ltd. Shareholding Pattern

5 Qtrs 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-09 (%) 2024-03 (%)
Promoter 67.47 67.47 67.47 67.47 67.47
Public 32.53 32.53 32.54 32.53 32.53
Depository Receipts 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00
No. of Shareholders (in Lacs)

JFL Life Sciences Ltd. Announcements

Thu, 11 Apr 2024
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Jfl Life Sciences Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
Thu, 11 Apr 2024
Updates
Jfl Life Sciences Limited has informed the Exchange regarding 'Non-Applicability of Corporate Governance Provisions to the Company.'.
Thu, 11 Apr 2024
Quarterly Compliance Report on Corporate governance - within 21 days from the end of the quarter
Jfl Life Sciences Limited has informed regarding Submission of the Compliance Report on Corporate Governance for the Q4 FY 2023-24

JFL Life Sciences Ltd. Technical Scans

Mon, 22 Apr 2024
High Delivery Percentage High Delivery Percentage
Higher Delivery Quantity Higher Delivery Quantity
Higher Delivery Quantity and Percentage Higher Delivery Quantity and Percentage
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity

JFL Life Sciences Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 369,401.61 1,484.65 -3.6%
Cipla Ltd. 109,341.46 1,346.70 -0.6%
Dr. Reddy's Laboratories Ltd. 100,341.19 5,952.10 -1.1%
Divi's Laboratories Ltd. 99,176.41 3,768.65 +0.8%
Zydus Lifesciences Ltd. 96,543.12 959.45 0.0%
Mankind Pharma Ltd. 93,651.57 2,393.05 +2.2%
Apollo Hospitals Enterprise Ltd. 89,650.45 6,194.90 -0.7%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 41.48 1,484.65 -3.6%
Cipla Ltd. Consolidated 2023-12 29.49 1,346.70 -0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 19.19 5,952.10 -1.1%
Divi's Laboratories Ltd. Consolidated 2023-12 71.71 3,768.65 +0.8%
Zydus Lifesciences Ltd. Consolidated 2023-12 32.46 959.45 0.0%
Mankind Pharma Ltd. Consolidated 2023-12 54.22 2,393.05 +2.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 113.58 6,194.90 -0.7%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 5.92 1,484.65 -3.6%
Cipla Ltd. Consolidated 2023-12 4.22 1,346.70 -0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.73 5,952.10 -1.1%
Divi's Laboratories Ltd. Consolidated 2023-12 7.61 3,768.65 +0.8%
Zydus Lifesciences Ltd. Consolidated 2023-12 5.12 959.45 0.0%
Mankind Pharma Ltd. Consolidated 2023-12 10.54 2,393.05 +2.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 13.27 6,194.90 -0.7%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,484.65 -3.6%
Cipla Ltd. Consolidated 2023-03 0.02 1,346.70 -0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,952.10 -1.1%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,768.65 +0.8%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 959.45 0.0%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 2,393.05 +2.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,194.90 -0.7%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,484.65 -3.6%
Cipla Ltd. Consolidated 2023-03 12.85 1,346.70 -0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,952.10 -1.1%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,768.65 +0.8%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 959.45 0.0%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,393.05 +2.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,194.90 -0.7%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,484.65 -3.6%
Cipla Ltd. Consolidated 2023-03 12.85 1,346.70 -0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,952.10 -1.1%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,768.65 +0.8%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 959.45 0.0%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,393.05 +2.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,194.90 -0.7%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,484.65 -3.6%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,346.70 -0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,952.10 -1.1%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,768.65 +0.8%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 959.45 0.0%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 2,393.05 +2.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,194.90 -0.7%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,484.65 -3.6%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,346.70 -0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,952.10 -1.1%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,768.65 +0.8%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 959.45 0.0%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 2,393.05 +2.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,194.90 -0.7%

JFL Life Sciences Ltd. FAQ's

What is JFL Life Sciences share price?

Can I buy JFL Life Sciences shares now?

What is the Market Cap of JFL Life Sciences?

What are the key metrics to analyse JFL Life Sciences?

What is the 52 Week High and Low of JFL Life Sciences?

What is the trend of JFL Life Sciences share price?